Organogenesis Holdings (ORGO) Consolidated Net Income (2017 - 2025)
Historic Consolidated Net Income for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.
- Organogenesis Holdings' Consolidated Net Income rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 3162.6%. This contributed to the annual value of -$9.9 million for FY2024, which is 29935.29% down from last year.
- As of Q3 2025, Organogenesis Holdings' Consolidated Net Income stood at $21.6 million, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Consolidated Net Income registered a high of $51.0 million during Q4 2021, and its lowest value of -$18.8 million during Q1 2025.
- Moreover, its 5-year median value for Consolidated Net Income was $3.2 million (2023), whereas its average is $5.2 million.
- As far as peak fluctuations go, Organogenesis Holdings' Consolidated Net Income surged by 137302.33% in 2023, and later tumbled by 79728.57% in 2025.
- Organogenesis Holdings' Consolidated Net Income (Quarter) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then crashed by 107.59% to -$568000.0 in 2023, then tumbled by 436.27% to -$3.0 million in 2024, then skyrocketed by 808.04% to $21.6 million in 2025.
- Its Consolidated Net Income stands at $21.6 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$18.8 million for Q1 2025.